InvestorsHub Logo
Followers 79
Posts 24601
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Wednesday, 03/20/2024 8:05:11 AM

Wednesday, March 20, 2024 8:05:11 AM

Post# of 27514
ATOS - 1.55 Pre-market at 1.63/1.64

Atossa Therapeutics shares are trading higher after the company provided a five-year on a breast cancer patient who received neoadjuvant and adjuvant (Z)-endoxifen therapy.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.